ClearPoint Neuro
CLPT
39 hedge funds and large institutions have $36.1M invested in ClearPoint Neuro in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 3 closing their positions.
367% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 3
361% more capital invested
Capital invested by funds: $7.84M → $36.1M (+$28.3M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
39% more funds holding
Funds holding: 28 → 39 (+11)
6.88% more ownership
Funds ownership: 6.61% → 13.48% (+6.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$4.15M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.26M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$950K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$625K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$496K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWM
Merriman Wealth Management
Seattle,
Washington
|
-$318K |
| 2 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$169K |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$114K |
| 4 |
IC
IEQ Capital
Foster City,
California
|
-$109K |
| 5 |
VF
Virtu Financial
New York
|
-$109K |
CLPT Hedge Fund Activity: Q4 2020 in Review
39 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q4 2020, worth a combined $36.1M — up 361% from $7.84M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new CLPT positions and 3 closed out — a net gain of 11 holders — while 11 added to existing stakes and 6 trimmed.
The largest buyer was Parian Global Management, opening a new position worth an estimated $4.15M. The largest seller was Merriman Wealth Management, cutting an estimated $318K.
- 39 institutional investors held ClearPoint Neuro (CLPT) as of Q4 2020, up from 28 in Q3 2020.
- Funds reported $36.1M of ClearPoint Neuro stock for Q4 2020, up 361% quarter-over-quarter.
- 14 funds opened new ClearPoint Neuro positions in Q4 2020 and 3 closed out, a net change of +11 holders.
- The largest ClearPoint Neuro buyer in Q4 2020 was Parian Global Management, an estimated $4.15M added.
- The largest ClearPoint Neuro seller in Q4 2020 was Merriman Wealth Management, an estimated $318K sold.
Based on aggregated 13F filings for Q4 2020.